Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in esophageal and GEJ cancer
NCT04018872Phase 2Recruiting
- Sponsor
- Dallas VA Medical Center
- Start
- Jun 2019
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in esophageal adenocarcinoma (EAC), Esophageal Squamous Cell Carcinoma (ESCC), gastroesophageal junction adenocarcinoma, sponsored by Dallas VA Medical Center. Started Jun 2019; status: recruiting.
02
Drugs
itraconazole
03
Conditions
esophageal adenocarcinoma (EAC)Esophageal Squamous Cell Carcinoma (ESCC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT04018872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018872.